RFM
TECH icon

Royal Fund Management’s Bio-Techne TECH Stock Holding History

Royal Fund Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-24
Closed -$1K – 730
2019
Q4 		$1K Sell
24
-72
-75% -$3.78K ﹤0.01% 603
2019
Q3 		$4K Buy
+96
New +$4.81K ﹤0.01% 474

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Royal Fund Management's TECH Position: Q1 2020 in Review

Royal Fund Management sold out of Bio-Techne (TECH) in Q1 2020, closing a stake of 24 shares — an estimated $1K sold.

Royal Fund Management first reported a position in TECH in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2019. 368 funds tracked by Wall St. Rank hold TECH as of Q1 2020.

  • Royal Fund Management reported no remaining Bio-Techne position as of Q1 2020 after selling out during the quarter.
  • Royal Fund Management sold 24 Bio-Techne shares in Q1 2020, an estimated $1K.
  • Royal Fund Management first reported a position in Bio-Techne in Q3 2019 and held it in 2 quarters.
  • Royal Fund Management's Bio-Techne position peaked at $4K in Q3 2019.
  • 368 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2020.

Based on Royal Fund Management's 13F filing for Q1 2020, filed 8 May 2020.